Great Point Partners as of Dec. 31, 2020
Portfolio Holdings for Great Point Partners
Great Point Partners holds 32 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gw Pharmaceuticals Ads | 7.3 | $45M | 390k | 115.41 | |
| Iovance Biotherapeutics (IOVA) | 6.9 | $43M | 917k | 46.40 | |
| Sage Therapeutics (SAGE) | 6.4 | $39M | 454k | 86.51 | |
| ACADIA Pharmaceuticals (ACAD) | 6.3 | $39M | 721k | 53.46 | |
| Rocket Pharmaceuticals (RCKT) | 6.2 | $38M | 700k | 54.84 | |
| Zymeworks | 6.1 | $38M | 800k | 47.26 | |
| Intersect Ent | 4.8 | $30M | 1.3M | 22.90 | |
| Constellation Pharmceticls I | 4.8 | $30M | 1.0M | 28.80 | |
| Macrogenics (MGNX) | 4.6 | $28M | 1.2M | 22.86 | |
| Vericel (VCEL) | 4.5 | $28M | 900k | 30.88 | |
| Arena Pharmaceuticals Com New | 4.3 | $27M | 345k | 76.83 | |
| Global Blood Therapeutics In | 4.2 | $26M | 596k | 43.31 | |
| United Therapeutics Corporation (UTHR) | 3.7 | $23M | 150k | 151.79 | |
| Ocular Therapeutix (OCUL) | 2.9 | $18M | 856k | 20.70 | |
| Kadmon Hldgs | 2.8 | $17M | 4.1M | 4.15 | |
| Insulet Corporation (PODD) | 2.5 | $15M | 60k | 255.63 | |
| Theravance Biopharma (TBPH) | 2.4 | $15M | 825k | 17.77 | |
| Arvinas Ord (ARVN) | 2.3 | $14M | 164k | 84.93 | |
| Puma Biotechnology (PBYI) | 2.2 | $13M | 1.3M | 10.26 | |
| Mersana Therapeutics (MRSN) | 2.1 | $13M | 488k | 26.61 | |
| Prothena Corp SHS (PRTA) | 1.9 | $12M | 978k | 12.01 | |
| Calithera Biosciences | 1.9 | $12M | 2.3M | 4.91 | |
| Exelixis (EXEL) | 1.5 | $9.5M | 475k | 20.07 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.4 | $8.4M | 421k | 20.03 | |
| Forma Therapeutics Hldgs SHS | 1.3 | $8.3M | 236k | 34.90 | |
| Geron Corporation (GERN) | 1.3 | $8.0M | 5.1M | 1.59 | |
| Fibrogen Call Option (FGEN) | 1.0 | $6.2M | 167k | 37.09 | |
| Pulmonx Corp (LUNG) | 0.7 | $4.4M | 64k | 69.02 | |
| Ionis Pharmaceuticals (IONS) | 0.7 | $4.2M | 75k | 56.55 | |
| Silverback Therapeutics (SPRY) | 0.5 | $3.2M | 70k | 46.34 | |
| Aurinia Pharmaceuticals (AUPH) | 0.4 | $2.4M | 175k | 13.83 | |
| Millendo Therapeutics | 0.1 | $578k | 270k | 2.14 |
